scholarly journals Utility of continuous electrocardiographic monitoring in pregnant women with cardiovascular disease

2021 ◽  
pp. 100305
Author(s):  
Paola Roldan ◽  
Lidija McGrath ◽  
Karishma Patel ◽  
Kathleen Brookfield ◽  
Emmanuelle Pare ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Pregnant Women ◽  
Electrocardiographic Monitoring

scholarly journals Hyperlipidemia in pregnancy

2011 ◽  
Vol 152 (19) ◽  
pp. 753-757 ◽  
Author(s):  
Tatjána Ábel ◽  
Anna Blázovics ◽  
Márta Kemény ◽  
Gabriella Lengyel
Keyword(s):  
Cardiovascular Disease ◽  
Acute Pancreatitis ◽  
Cohort Studies ◽  
Pregnant Women ◽  
Breast Feeding ◽  
Normal Pregnancy ◽  
Large Cohort ◽  
Physiological Changes ◽  
Teratogenic Effects ◽  
In Pregnancy

Physiological changes in lipoprotein levels occur in normal pregnancy. Women with hyperlipoproteinemia are advised to discontinue statins, fibrates already when they consider pregnancy up to and including breast-feeding the newborn, because of the fear for teratogenic effects. Hypertriglyceridemia in pregnancy can rarely lead to acute pancreatitis. Management of acute pancreatitis in pregnant women is similar to that used in non-pregnant patients. Further large cohort studies are needed to estimate the consequence of supraphysiologic hyperlipoproteinemia or extreme hyperlipoproteinemia in pregnancy on the risk for cardiovascular disease later in life. Orv. Hetil., 2011, 152, 753–757.

scholarly journals Risk Factors for Cardiovascular Events among Pregnant Women with Cardiovascular Disease

2020 ◽  
Vol 59 (9) ◽  
pp. 1119-1124
Author(s):  
Masafumi Nii ◽  
Hiroaki Tanaka ◽  
Kayo Tanaka ◽  
Shinji Katsuragi ◽  
Chizuko A Kamiya ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Pregnant Women ◽  
Cardiovascular Events

scholarly journals Racial/Ethnic Disparities in Screening for and Awareness of High Cholesterol Among Pregnant Women Receiving Prenatal Care

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Reed Mszar ◽  
Dipika J. Gopal ◽  
Rupa Chowdary ◽  
Cara Lea Smith ◽  
Cara D. Dolin ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Risk Factor ◽  
Prenatal Care ◽  
Pregnant Women ◽  
Disease Risk ◽  
Atherosclerotic Cardiovascular Disease ◽  
High Cholesterol ◽  
Younger Women ◽  
Lipid Screening ◽  
Racial Ethnic

Background Atherosclerotic cardiovascular disease remains a leading cause of morbidity and mortality among women, with younger women being disproportionately affected by traditional cardiovascular risk factors such as dyslipidemia. Despite recommendations for lipid screening in early adulthood and the risks associated with maternal dyslipidemia during pregnancy, many younger women lack access to and utilization of early screening. Accordingly, our objective was to assess the prevalence of and disparities in lipid screening and awareness of high cholesterol as an atherosclerotic cardiovascular disease risk factor among pregnant women receiving prenatal care. Methods and Results We invited 234 pregnant women receiving prenatal care at 1 of 3 clinics affiliated with the University of Pennsylvania Health System to complete our survey. A total of 200 pregnant women (86% response rate) completed the survey. Overall, 59% of pregnant women (mean age 32.2 [±5.7] years) self‐reported a previous lipid screening and 79% of women were aware of high cholesterol as an atherosclerotic cardiovascular disease risk factor. Stratified by racial/ethnic subgroups, non‐Hispanic Black women were less likely to report a prior screening (43% versus 67%, P =0.022) and had lower levels of awareness (66% versus 92%, P <0.001) compared with non‐Hispanic White women. Non‐Hispanic Black women were more likely to see an obstetrician/gynecologist for their usual source of non‐pregnancy care compared with non‐Hispanic White women (18% versus 5%, P =0.043). Those seeing an obstetrician/gynecologist for usual care were less likely to report a prior lipid screening compared with those seeing a primary care physician (29% versus 63%, P =0.007). Conclusions Significant racial/ethnic disparities persist in lipid screening and risk factor awareness among pregnant women. Prenatal care may represent an opportunity to enhance access to and uptake of screening among younger women and reduce variations in accessing preventive care services.

scholarly journals Beta-Blockers and Fetal Growth Restriction in Pregnant Women With Cardiovascular Disease

2016 ◽  
Vol 80 (10) ◽  
pp. 2221-2226 ◽  
Author(s):  
Kayo Tanaka ◽  
Hiroaki Tanaka ◽  
Chizuko Kamiya ◽  
Shinji Katsuragi ◽  
Masami Sawada ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Pregnant Women ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Beta Blockers ◽  
Growth Restriction

scholarly journals SARS, MERS, COVID-19: Identification of Patients at a Higher Risk: A Narrative Review

2021 ◽  
Vol 2 (1) ◽  
pp. 57-70
Author(s):  
Hussein Noureldine ◽  
Georges Chedid ◽  
Jad Gerges Harb ◽  
Wared Nour-Eldine ◽  
Mariam Nour Eldine ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Cardiovascular Disease ◽  
High Risk ◽  
Pregnant Women ◽  
Early Identification ◽  
Factors Associated ◽  
High Risk Patients ◽  
Increased Risk ◽  
Risk Patients

The different presentations, comorbidities, and outcomes of COVID-19 highlight the importance of early identification and proper triage of patients. High-risk patients can be divided into patients with common comorbidities and patients with special categories. Common comorbidities include, but are not limited to, Cardiovascular Disease (CVD), Diabetes Mellitus (DM), immunosuppression, underlying respiratory disease, and obesity. Certain categories of COVID-19 patients are also at increased risk, including neonates and pregnant women.  In the present article, we delineate the reported risk factors for acquisition of infection, and for increased severity of the clinical disease. We also comparatively analyze those risk factors associated with COVID-19 and with the antecedent human acute respiratory syndrome-causing viruses, SARS-CoV-1 and MERS-CoV. We hypothesize that the structural similarities of the three viruses predict a similarity in the profile of high-risk patients. Several pathophysiological patterns have been detected to support this theory.

scholarly journals Labour analgesia and obstetric outcome in heart disease complicating pregnancy in tertiary care center

2020 ◽  
Vol 9 (3) ◽  
pp. 1234
Author(s):  
Subha Sivagami Sengodan ◽  
Dhivya Sharona
Keyword(s):  
Cardiovascular Disease ◽  
Cesarean Section ◽  
Epidural Analgesia ◽  
Pregnant Women ◽  
Cardiovascular Events ◽  
Care Center ◽  
Tertiary Care ◽  
Labour Analgesia ◽  
Obstetric Outcome ◽  
The Impact

Background: One of the most severe pain experienced by a woman is during child birth. It is imperative to understand the pain transmission for providing labour analgesia. Hemodynamic status in labour fluctuates greatly during uterine contraction and true labour pains. Therefore, pregnant women with cardiovascular disease need epidural anaesthesia during labour depending upon the type of cardiovascular disease. Objective of this study was to assess the impact of labour analgesia and the obstetric outcome and cardiac events during labour.Methods: This is an observational study conducted in 46 pregnant women with cardiovascular disease during the period of January 2019 to December 2019 (12 months).Results: A total of 46 antenatal mother with cardiovascular disease was admitted in the department of obstetrics and gynecology over a period of one year out of which 25 patients who had epidural analgesia during labour and 21 patients who had no epidural analgesia during labour. Cardiovascular events significantly reduced in epidural group (25 patients) and there was no increase in cesarean section in epidural group.Conclusions: The data showed there was significant decrease in cardiovascular events related to arrhythmia hence decreased maternal morbidity and mortality. There was no associated increase in cesarean section rate but slight increase in instrumental vaginal delivery.

Sign in / Sign up

Export Citation Format

Share Document